FutureMeds

FutureMeds is an independent European network of dedicated research sites and decentralized clinical trial (DCT) service provider. It specializes in patient-centric recruitment, streamlined clinical trial delivery, and proven DCT solutions. Since its founding in 2019, it has delivered over 320 projects across more than 120 indications from Phase I to IV. The company operates over 27 dedicated research sites in at least six countries with DCT capabilities spanning eighteen countries. Its model emphasizes high-quality data generation, rapid patient recruitment/retention strategies, and strong partnerships with sponsors/CROs to accelerate access to new treatments for patients throughout Europe[1][3][4][5][6].